PNC Financial Services Group’s Arcturus Therapeutics ARCT Stock Holding History

PNC Financial Services Group’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.02K	Sell	1,045 -13	-1%	-$102	﹤0.01%	4254
2026 Q1	$8.17K	Buy	1,058 +439	+71%	+$3.2K	﹤0.01%	4042
2025 Q4	$3.79K	Buy	619 +481	+349%	+$5.2K	﹤0.01%	4337
2025 Q3	$2.54K	Hold	138	–	–	﹤0.01%	4437
2025 Q2	$1.79K	Buy	138 +85	+160%	+$1K	﹤0.01%	4440
2025 Q1	$561	Buy	53 +45	+563%	+$714	﹤0.01%	4616
2024 Q4	$136	Hold	8	–	–	﹤0.01%	4691
2024 Q3	$186	Hold	8	–	–	﹤0.01%	4685
2024 Q2	$195	Sell	8 -12	-60%	-$364	﹤0.01%	4671
2024 Q1	$675	Buy	+20	New	+$709	﹤0.01%	4445
2014 Q3	–	Sell	-143	Closed	-$17K	–	3974
2014 Q2	$17K	Hold	143	–	–	﹤0.01%	2980
2014 Q1	$18K	Buy	+143	New	+$21.2K	﹤0.01%	2873

Other funds holding ARCT

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

PNC Financial Services Group's ARCT Position: Q2 2026 in Review

PNC Financial Services Group reduced its Arcturus Therapeutics (ARCT) stake by 1.2% in Q2 2026, selling an estimated $102 and leaving 1,045 shares worth $7.02K. The position accounts for ﹤0.01% of the portfolio, ranked #4254.

PNC Financial Services Group first reported a position in ARCT in Q1 2014 and has held it in 12 quarters since. The position peaked at $18K in Q1 2014. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

PNC Financial Services Group held 1,045 shares of Arcturus Therapeutics worth $7.02K as of Q2 2026.
PNC Financial Services Group sold 13 Arcturus Therapeutics shares in Q2 2026, an estimated $102.
Arcturus Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4254 holding.
PNC Financial Services Group first reported a position in Arcturus Therapeutics in Q1 2014 and has held it in 12 quarters since.
PNC Financial Services Group's Arcturus Therapeutics position peaked at $18K in Q1 2014.
135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.